• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

China

blackstone-logo
Blackstone's Ed Huang switches to Asia private wealth role

Ed Huang, who has spent the last two-and-a-half years as COO of The Blackstone Group’s Asia private equity business, will become the firm’s head of private wealth solutions for the region.

  • Greater China
  • 16 October 2023
didi-autonomous-driving
China's Didi gets backing from state-owned carmaker

China ride-hailing platform Didi, which delisted from the New York Stock Exchange last year following a scandal-hit post-IPO period, has raised USD 149m in funding from state-backed carmaker GAC Group.

  • Greater China
  • 13 October 2023
electric-vehicle-charging-ev
Shangqi hits $575m second close on renminbi fund

Shangqi Capital, a private equity affiliate of Chinese automotive manufacturer SAIC Motor, has completed a second close of CNY 4.2bn (USD 575m) on its latest renminbi-denominated fund, bettering the overall target of CNY 4bn.

  • Greater China
  • 13 October 2023
avcj-231011cvr-72
Weekly digest - October 11 2023

  • Region
  • 12 October 2023
data-code-computing
State-linked investors back Series D for China's DataCanvas

DataCanvas, a China-based artificial intelligence-driven (AI) big data solutions provider, has raised CNY 300m (USD 41m) in a first tranche of Series D funding with strong support from investors with ties to national-level state-owned enterprises (SOEs).

  • Greater China
  • 11 October 2023
chicken-broiler-poultry
Trustar, Bain, BPEA EQT target Tyson Foods' China poultry business

US-based meat and processed food maker Tyson Foods has received preliminary bids from private equity firms including Trustar Capital, Bain Capital and BPEA EQT for its China poultry business, according to two sources familiar with the matter.

  • Greater China
  • 10 October 2023
semiconductor-chip-03
China's Leadrive raises $81m Series D

Legend Capital and Oriza FoFs have led a CNY 600m (USD 81m) Series D round for Leadrive, a Shanghai-headquartered manufacturer of semiconductor power modules and motor control units used in electric vehicles (EVs).

  • Greater China
  • 10 October 2023
ecommerce-online-shopping-7
China-US consumer brand accelerator raises $58m

SuperOrdinary, a global consumer brands accelerator that operates out of Shanghai, New York, and Los Angeles, has raised USD 58m in Series B funding at a valuation of more than USD 800m.

  • Greater China
  • 09 October 2023
avcj-231004cvr-72
Weekly digest - October 04 2023

  • Region
  • 04 October 2023
separation-split
China VC: Amicable divorces

Regulatory pressures are encouraging Chinese VC firms to end longstanding US affiliations, but the impact of impending legislation – even sight unseen – cuts deeper into investor sentiment on China

  • Greater China
  • 04 October 2023
china-map-globe2
Temasek's True Light Capital raises $3.3b China fund

True Light Capital, a Singapore-based asset manager established by Temasek Holdings, has raised USD 3.3bn for a fund that invests in companies that have a nexus to or a major business relationship with Greater China.

  • Greater China
  • 29 September 2023
biotech-lab-healthcare-pharma-02
L Catterton backs beauty industry biotech supplier

L Catterton has led a CNY 200m (USD 27m) Series B round for Trautec, a China-based biotech start-up that develops synthetic proteins used in beauty and healthcare products.

  • Central Asia
  • 29 September 2023
dcm
DCM adds partners in Japan, China

DCM has promoted two Asia-based investment professionals – Kenichiro Hara and Fiona Huang, who focus on Japan and China, respectively – to partner.

  • Greater China
  • 28 September 2023
healthcare-medical-technology
China healthcare AI start-up Huimei gets $41m Series D

Eastern Bell Capital has led a Series D round of more than CNY 300m (USD 41m) for Huimei Cloud Technology, a China-based provider of artificial intelligence-enabled (AI) software that helps doctors make clinical decisions.

  • Greater China
  • 28 September 2023
avcj-230927cvr-72
Weekly digest - September 27 2023

  • Region
  • 27 September 2023
stock-shares-ipo-2
China GP Tiantu Capital targets $253m Hong Kong IPO

Chinese consumer-focused venture capital firm Tiantu Capital has launched a Hong Kong IPO with a view to raising as much as HKD 1.9bn (USD 253m).

  • Greater China
  • 27 September 2023
cinema-movie-audience
PAG to buy cinema business from Chinese property developer

PAG has agreed to acquire Shanghai Xingyi Cinema Management from Hong Kong-listed property developer Seazen for about CNY 1.4bn (USD 187m).

  • Greater China
  • 27 September 2023
cainiao
Alibaba confirms Hong Kong IPO plan for logistics unit

Alibaba Group’s logistics unit has filed for an IPO in Hong Kong, potentially creating liquidity events for private equity backers such as Yunfeng Capital, Primavera Capital Group, and Princeville Global, as well as for GIC, Temasek Holdings, and Khazanah...

  • Greater China
  • 27 September 2023
biotech-lab-drug-research-development
Matrix, HongShan back China's Qihan Biotech

Matrix Partners China and HongShan (formerly Sequioa Capital China) have joined a USD 16m pre-Series B round for Qihan Biotech, a genome editing player active in human and agricultural therapies.

  • Greater China
  • 26 September 2023
biotech-lab-healthcare-drug
China's Lynk Pharmaceutical increases Series C to $44m

China-based drug developer Lynk Pharmaceuticals has closed a second tranche of Series C funding, taking the overall size of the round to CNY 322m (USD 44m).

  • Greater China
  • 25 September 2023
separation-split
GGV to spin off Asia operation

GGV Capital’s Asia business will sever ties with the firm’s international operation – switching to separate partnerships and a distinct brand – as venture capital continues to feel the impact of the US and China’s conflicting technology agendas.

  • Greater China
  • 22 September 2023
avcj-230920cvr-72
Weekly digest - September 20 2023

  • Region
  • 20 September 2023
doctor-xray-cancer-hospital
PE-backed Concord Healthcare pursues HK IPO

Concord Healthcare Group, an onshore subsidiary of US-listed Chinese healthcare business Concord Medical, has filed for an IPO in Hong Kong.

  • Greater China
  • 20 September 2023
test-tube-chemistry-lab
China's Canton Biologics raises $41m Series C

Chinese pharmaceutical industry services provider Canton Biologics has completed a CNY 300m (USD 41m) Series C round led by state-owned SDIC Venture Capital.

  • Greater China
  • 20 September 2023
1 2 3
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013